{
    "code": "01041037",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01041037",
    "time": "2022-11-18 06:11:12",
    "許可證字號": "衛署藥製字第041037號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/09\/18",
    "發證日期": "87\/09\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104103702",
    "中文品名": "力得微脂體注射劑2毫克\/毫升（鹽酸杜薩魯比辛）",
    "英文品名": "LIPO-DOX LIPOSOME INJECTION 2MG\/ML(DOXORUBICIN HYDROCHLORIDE)",
    "適應症": "用於治療CD4數量低下(",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 5\/10公撮小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
    "限制項目": "01國　產",
    "申請商名稱": "6201125122  台灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "1406804300  臺灣東洋藥品工業股份有限公司中壢廠",
            "製造廠廠址": "桃園市中壢區中華路一段８３８號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000615",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
            "含量描述": "(POTENCY)",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "橘紅色至近紅色注射液",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "010410370004 藥物外觀-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "力得微脂體注射劑2毫克毫升(衛署藥製041037號)_仿單-109-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=003&Type=9"
        },
        {
            "title": "010410370001 仿單-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=002&Type=9"
        },
        {
            "title": "力得微脂體注射劑2毫克毫升(衛署藥製041037號)_外盒-109-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=010&Type=8"
        },
        {
            "title": "力得微脂體注射劑2毫克毫升(衛署藥製041037號)_標籤-109-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=009&Type=8"
        },
        {
            "title": "Lipo-Dox 標籤-2LB01233(A05)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=007&Type=8"
        },
        {
            "title": "Lipo-Dox 外盒-1vial-2CT01233(A04)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=006&Type=8"
        },
        {
            "title": "Lipo-Dox 標籤-2LB01233(A05)-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=008&Type=8"
        },
        {
            "title": "010410370003 外盒-105-01-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=004&Type=8"
        },
        {
            "title": "010410370002 瓶標-105-01-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=003&Type=8"
        },
        {
            "title": "010410370003 外盒-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=002&Type=8"
        },
        {
            "title": "010410370002 瓶標-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=001&Type=8"
        }
    ]
}